US 12194150
Levodopa dosing regimen
granted A61KA61K31/198A61K9/1617
Quick answer
US patent 12194150 (Levodopa dosing regimen) held by AMNEAL PHARMACEUTICALS LLC expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AMNEAL PHARMACEUTICALS LLC
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/198, A61K9/1617, A61K9/1635, A61K9/1652